Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2000
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061566A1 Process for preparing mkc-442
10/19/2000WO2000061564A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061563A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061562A1 Neurotrophic substituted pyrimidines
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061231A2 Medical use
10/19/2000WO2000061134A1 Antimicrobial agents
10/19/2000DE19917160A1 New disubstituted pyridine or pyrimidine derivatives, useful as total or selective herbicides or as microbicides, especially fungicides, for plant protection
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2369698A1 Process for preparing mkc-442
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044968A1 6-Amino-2-(thi)oxo-pyrimidin-4-one and 7-amino- 2,3-dihydrooxazolo[2,3-b]pyrimidin-5-one derivatives, their preparation and their use as stabilisers for halogen-containing polymers
10/18/2000EP1044952A2 High transverse dipole moment aryl compounds
10/18/2000EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
10/18/2000EP0823901B1 Quinazoline derivative
10/18/2000EP0633886B1 Pharmaceutically active bicyclic-heterocyclic amines
10/18/2000CN1270593A Pyrimidin-4-one and pyrimidin-4-thione as fungicide
10/18/2000CN1270590A Novel compounds
10/18/2000CN1270583A Substituted phenyluracils
10/18/2000CN1270168A Magnolol series of compounds, synthesizing process thereof, and medicinal composition using same as active component
10/18/2000CN1270167A Optically active ureido-pyrimidine compounds
10/18/2000CN1057525C Process improvement in synthesis of N-[3-(3-cyanopyrazolo [1,5-alpha] pyrimidin-7-yl] phenyli-N-ethyl-acetamide
10/18/2000CN1057443C Method for preparing antiviral medicinal compositions
10/17/2000US6133444 Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133338 Typified by 6-methacryloyloxyhexyl 2-thiouracil-5-carboxylate, a radical-polymerizable monomer, and a polymerization initiator; dental adhesive; good adhesiveness to noble metals and alloys thereof
10/17/2000US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000CA2114300C Quinoline or quinazoline derivatives, their production and use
10/12/2000WO2000059906A1 Aminoheterocycle-substituted glycerols
10/12/2000WO2000059894A1 Cross-linking agent based on pyrimidine used for thermohardenable compositions
10/12/2000WO2000059893A1 Neurotrophic thio substituted pyrimidines
10/12/2000WO2000059892A1 Pyrimidine compounds with pharmaceutical activity
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059304A1 Compositions and methods for preventing and treating sexual dysfunctions
10/12/2000WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
10/12/2000DE19915388A1 4-Aminopyrimidinone und Oxazolidino-4-amino-pyrimidinone, Verfahren zu deren Herstellung und ihre Verwendung zum Stabilisieren von halogenhaltigen Polymeren 4-Aminopyrimidinone and oxazolidino-4-amino-pyrimidinones, to processes for their preparation and their use for stabilizing halogen-containing polymers
10/12/2000CA2484282A1 Pyrimidine derivatives intermediates for producing aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000CA2369945A1 Neurotrophic thio substituted pyrimidines
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2369032A1 Cross-linking agent based on pyrimidine used for thermohardenable compositions
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000EP1043318A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
10/11/2000EP1043299A2 Liquid crystalline compound, liquid crystal composition comprising the liquid crystalline compound, and liquid crystal display device using the liquid crystal composition
10/11/2000EP1042356A2 Intermediates and process for the synthesis of 17-unsubstituted 16.beta.-aryloxy 4-azasteroids
10/11/2000EP1042303A1 Chloropyrimidine process
10/11/2000EP1042302A1 Liquid crystal compounds having a chiral fluorinated terminal portion
10/11/2000EP1042301A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1041989A1 Novel cycloalkenyl substituted compounds
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000CN1269793A Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-40thione derivatives
10/11/2000CN1269792A Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin-receptor atagonists
10/10/2000US6130251 Use as agents for combating pests.
10/10/2000US6130225 Substituted p-trifluoromethylphenyluracils
10/10/2000US6130223 Thienopyrimidine with phosphodiesterase V inhibiting effect
10/10/2000US6130215 Central nervous system
10/10/2000US6130214 Benzothiazin and benzoxazin derivatives; their preparation and uses
10/10/2000US6130209 Cascading polymers
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/05/2000WO2000058306A1 Substituted benzoylpyrazoles as herbicides
10/05/2000WO2000058293A2 Glucokinase activators
10/05/2000WO2000029088A3 Recovery of organic solutes from aqueous solutions
10/05/2000DE19914898A1 Pyrimidine crosslinking agents are useful for production of coatings, adhesives, sealants and molded articles
10/05/2000CA2368459A1 Substituted benzoylpyrazoles as herbicides
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1040831A2 Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1039910A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
10/04/2000EP0772439B1 Novel antibiotic compounds and antibiotic compositions comprising said compounds for inhibiting gram positive bacteria and mycoplasma cells.
10/04/2000EP0569384B2 Fungicides
10/04/2000CN1268942A Sulfonamide compounds and medicinal use thereof
10/04/2000CN1057086C Phenylsulfonyl ureas, process for preparing same, and use as herbicide, herbicide composition contg. same
10/04/2000CN1056958C Pesticide composition and use thereof
10/03/2000US6127568 Phenylacetic acid derivatives, preparation thereof and intermediates thereof, and compositions containing them
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127374 An enzyme inhibitor for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis
10/03/2000US6126917 Epidermal growth factor receptor binding compounds for positron emission tomography
09/2000
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056720A1 Quinazolines and therapeutic use thereof
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056338A1 Quinazoline formulations and therapeutic use thereof
09/28/2000WO2000056337A1 Agents for relieving side effects
09/28/2000WO2000044727B1 Inhibitors for the biosynthesis of vitamin b2 and method for producing same
09/28/2000DE19914140A1 Substituierte Benzoylpyrazole Substituted benzoylpyrazoles
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2367861A1 Quinazolines and therapeutic use thereof
09/28/2000CA2366998A1 Quinazoline formulations and therapeutic use thereof
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 427